GSEC (G-quadruplex forming sequence containing lncRNA) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: GSEC (G-quadruplex forming sequence containing lncRNA) Homo sapiens
Analyze
Symbol: GSEC
Name: G-quadruplex forming sequence containing lncRNA
RGD ID: 7245808
HGNC Page HGNC:48645
Description: ASSOCIATED WITH Al-Raqad Syndrome; genetic disease; Schizophrenia; INTERACTS WITH antirheumatic drug; aristolochic acid A; belinostat
Type: ncrna (Ensembl: lncRNA)
RefSeq Status: VALIDATED
Previously known as: DCPS-AS1; ST3GAL4 antisense RNA 1 (head to head); ST3GAL4-AS1
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh3811126,341,716 - 126,355,587 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl11126,340,882 - 126,355,587 (-)EnsemblGRCh38hg38GRCh38
GRCh3711126,211,611 - 126,225,482 (-)NCBIGRCh37GRCh37hg19GRCh37
Celera11123,376,770 - 123,390,639 (-)NCBICelera
Cytogenetic Map11q24.2NCBI
HuRef11122,156,458 - 122,170,332 (-)NCBIHuRef
CHM1_111126,097,877 - 126,111,748 (-)NCBICHM1_1
T2T-CHM13v2.011126,373,121 - 126,386,992 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
Schizophrenia  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:14702039   PMID:16344560   PMID:27797375   PMID:32868080   PMID:34907156   PMID:36049364  


Genomics

Variants

.
Variants in GSEC
27 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 11q24.1-25(chr11:123799938-134998526)x1 copy number loss See cases [RCV000134708] Chr11:123799938..134998526 [GRCh38]
Chr11:123670646..134868420 [GRCh37]
Chr11:123175856..134373630 [NCBI36]
Chr11:11q24.1-25		 pathogenic
GRCh38/hg38 11q24.2-25(chr11:124205225-134998526)x1 copy number loss See cases [RCV000134731] Chr11:124205225..134998526 [GRCh38]
Chr11:124075932..134868420 [GRCh37]
Chr11:123581142..134373630 [NCBI36]
Chr11:11q24.2-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:116851372-134998526)x3 copy number gain See cases [RCV000134064] Chr11:116851372..134998526 [GRCh38]
Chr11:116722088..134868420 [GRCh37]
Chr11:116227298..134373630 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q24.2-25(chr11:126046358-134998513)x1 copy number loss See cases [RCV000136595] Chr11:126046358..134998513 [GRCh38]
Chr11:125916253..134868407 [GRCh37]
Chr11:125421463..134373617 [NCBI36]
Chr11:11q24.2-25		 pathogenic
GRCh38/hg38 11q24.2-25(chr11:125241472-134998513)x1 copy number loss See cases [RCV000136612] Chr11:125241472..134998513 [GRCh38]
Chr11:125111368..134868407 [GRCh37]
Chr11:124616578..134373617 [NCBI36]
Chr11:11q24.2-25		 pathogenic
GRCh38/hg38 11q23.2-25(chr11:112864326-131189315)x3 copy number gain See cases [RCV000137582] Chr11:112864326..131189315 [GRCh38]
Chr11:112832130..131059210 [GRCh37]
Chr11:112240259..130564420 [NCBI36]
Chr11:11q23.2-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:116868935-135075271)x3 copy number gain See cases [RCV000137453] Chr11:116868935..135075271 [GRCh38]
Chr11:116739651..134945165 [GRCh37]
Chr11:116244861..134450377 [NCBI36]
Chr11:11q23.3-25		 pathogenic|conflicting data from submitters
GRCh38/hg38 11q24.1-25(chr11:121780459-135075271)x1 copy number loss See cases [RCV000138014] Chr11:121780459..135075271 [GRCh38]
Chr11:121651167..134945165 [GRCh37]
Chr11:121156377..134450377 [NCBI36]
Chr11:11q24.1-25		 pathogenic
GRCh38/hg38 11q24.2-25(chr11:126046358-135075271)x1 copy number loss See cases [RCV000138163] Chr11:126046358..135075271 [GRCh38]
Chr11:125916253..134945165 [GRCh37]
Chr11:125421463..134450377 [NCBI36]
Chr11:11q24.2-25		 pathogenic
GRCh38/hg38 11q24.2-25(chr11:124940059-135075271)x1 copy number loss See cases [RCV000138675] Chr11:124940059..135075271 [GRCh38]
Chr11:124809955..134945165 [GRCh37]
Chr11:124315165..134450377 [NCBI36]
Chr11:11q24.2-25		 pathogenic|likely benign
GRCh38/hg38 11q23.3-25(chr11:120515759-135075271)x1 copy number loss See cases [RCV000138373] Chr11:120515759..135075271 [GRCh38]
Chr11:120386468..134945165 [GRCh37]
Chr11:119891678..134450377 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:116806268-135075271)x3 copy number gain See cases [RCV000138307] Chr11:116806268..135075271 [GRCh38]
Chr11:116676984..134945165 [GRCh37]
Chr11:116182194..134450377 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q24.1-25(chr11:123963074-135075271)x1 copy number loss See cases [RCV000138544] Chr11:123963074..135075271 [GRCh38]
Chr11:123833781..134945165 [GRCh37]
Chr11:123338991..134450377 [NCBI36]
Chr11:11q24.1-25		 pathogenic
GRCh38/hg38 11q23.3-24.2(chr11:117333952-127709156)x3 copy number gain See cases [RCV000139362] Chr11:117333952..127709156 [GRCh38]
Chr11:117204668..127579051 [GRCh37]
Chr11:116709878..127084261 [NCBI36]
Chr11:11q23.3-24.2		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:119424297-135075271)x1 copy number loss See cases [RCV000138947] Chr11:119424297..135075271 [GRCh38]
Chr11:119295007..134945165 [GRCh37]
Chr11:118800217..134450377 [NCBI36]
Chr11:11q23.3-25		 pathogenic|likely benign
GRCh38/hg38 11q24.2-25(chr11:126199589-135075271)x1 copy number loss See cases [RCV000139117] Chr11:126199589..135075271 [GRCh38]
Chr11:126069484..134945165 [GRCh37]
Chr11:125574694..134450377 [NCBI36]
Chr11:11q24.2-25		 pathogenic
GRCh38/hg38 11q24.2-25(chr11:124315025-134818116)x1 copy number loss See cases [RCV000139907] Chr11:124315025..134818116 [GRCh38]
Chr11:124184921..134688010 [GRCh37]
Chr11:123690131..134193220 [NCBI36]
Chr11:11q24.2-25		 pathogenic
GRCh38/hg38 11q24.1-25(chr11:121689052-135075271)x1 copy number loss See cases [RCV000139622] Chr11:121689052..135075271 [GRCh38]
Chr11:121559760..134945165 [GRCh37]
Chr11:121064970..134450377 [NCBI36]
Chr11:11q24.1-25		 pathogenic|likely benign
GRCh38/hg38 11q24.1-25(chr11:121806547-135068576)x1 copy number loss See cases [RCV000142210] Chr11:121806547..135068576 [GRCh38]
Chr11:121677255..134938470 [GRCh37]
Chr11:121182465..134443680 [NCBI36]
Chr11:11q24.1-25		 pathogenic
GRCh38/hg38 11q24.1-25(chr11:121611476-135068576)x1 copy number loss See cases [RCV000142185] Chr11:121611476..135068576 [GRCh38]
Chr11:121482185..134938470 [GRCh37]
Chr11:120987395..134443680 [NCBI36]
Chr11:11q24.1-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:116851395-134998513)x3 copy number gain See cases [RCV000148276] Chr11:116851395..134998513 [GRCh38]
Chr11:116722111..134868407 [GRCh37]
Chr11:116227321..134373617 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q24.2-25(chr11:124155723-134998513)x1 copy number loss See cases [RCV000050865] Chr11:124155723..134998513 [GRCh38]
Chr11:124026430..134868407 [GRCh37]
Chr11:123531640..134373617 [NCBI36]
Chr11:11q24.2-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:118789765-134998513)x3 copy number gain See cases [RCV000051213] Chr11:118789765..134998513 [GRCh38]
Chr11:118660474..134868407 [GRCh37]
Chr11:118165684..134373617 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:119433909-134998513)x1 copy number loss See cases [RCV000050905] Chr11:119433909..134998513 [GRCh38]
Chr11:119304619..134868407 [GRCh37]
Chr11:118809829..134373617 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q24.2-24.3(chr11:125891315-129072391)x1 copy number loss See cases [RCV000050926] Chr11:125891315..129072391 [GRCh38]
Chr11:125761210..128942286 [GRCh37]
Chr11:125266420..128447496 [NCBI36]
Chr11:11q24.2-24.3		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:116851395-134998513)x3 copy number gain See cases [RCV000050331] Chr11:116851395..134998513 [GRCh38]
Chr11:116722111..134868407 [GRCh37]
Chr11:116227321..134373617 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:119215032-134998654)x1 copy number loss See cases [RCV000052715] Chr11:119215032..134998654 [GRCh38]
Chr11:119085742..134868548 [GRCh37]
Chr11:118590952..134373758 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:120507265-134576266)x1 copy number loss See cases [RCV000052716] Chr11:120507265..134576266 [GRCh38]
Chr11:120377974..134446160 [GRCh37]
Chr11:119883184..133951370 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q22.1-25(chr11:100348599-135040246)x3 copy number gain See cases [RCV000053638] Chr11:100348599..135040246 [GRCh38]
Chr11:100219331..134910140 [GRCh37]
Chr11:99724541..134415350 [NCBI36]
Chr11:11q22.1-25		 pathogenic
GRCh38/hg38 11q23.3-25(chr11:120236432-135040246)x3 copy number gain See cases [RCV000053643] Chr11:120236432..135040246 [GRCh38]
Chr11:120107141..134910140 [GRCh37]
Chr11:119612351..134415350 [NCBI36]
Chr11:11q23.3-25		 pathogenic
GRCh38/hg38 11q24.1-25(chr11:123753493-134998513)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053645]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053645]|See cases [RCV000053645] Chr11:123753493..134998513 [GRCh38]
Chr11:123624201..134868407 [GRCh37]
Chr11:123129411..134373617 [NCBI36]
Chr11:11q24.1-25		 pathogenic
NM_014026.6(DCPS):c.769C>T (p.Arg257Trp) single nucleotide variant not provided [RCV000593631] Chr11:126345368 [GRCh38]
Chr11:126215263 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.947C>T (p.Thr316Met) single nucleotide variant Al-Raqad syndrome [RCV000412619] Chr11:126345546 [GRCh38]
Chr11:126215441 [GRCh37]
Chr11:11q24.2		 pathogenic|likely pathogenic
NM_014026.6(DCPS):c.677G>A (p.Gly226Asp) single nucleotide variant Al-Raqad syndrome [RCV000988766]|DCPS-related condition [RCV003932545]|Inborn genetic diseases [RCV002524709]|not provided [RCV000423311] Chr11:126343347 [GRCh38]
Chr11:126213242 [GRCh37]
Chr11:11q24.2		 benign|likely benign
NM_014026.6(DCPS):c.791G>A (p.Arg264Gln) single nucleotide variant not provided [RCV000439539] Chr11:126345390 [GRCh38]
Chr11:126215285 [GRCh37]
Chr11:11q24.2		 conflicting interpretations of pathogenicity|uncertain significance
Single allele duplication Schizophrenia [RCV000754124] Chr11:118989374..135076622 [GRCh38]
Chr11:11q23.3-25		 likely pathogenic
NM_014026.6(DCPS):c.804C>T (p.His268=) single nucleotide variant DCPS-related condition [RCV003970540]|not provided [RCV000926689] Chr11:126345403 [GRCh38]
Chr11:126215298 [GRCh37]
Chr11:11q24.2		 benign|likely benign
NM_014026.6(DCPS):c.977C>G (p.Pro326Arg) single nucleotide variant not provided [RCV000891577] Chr11:126345576 [GRCh38]
Chr11:126215471 [GRCh37]
Chr11:11q24.2		 likely benign
NM_014026.6(DCPS):c.918G>C (p.Glu306Asp) single nucleotide variant Al-Raqad syndrome [RCV001090050] Chr11:126345517 [GRCh38]
Chr11:126215412 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.1013G>A (p.Ter338=) single nucleotide variant DCPS-related condition [RCV003935849]|not provided [RCV000955197] Chr11:126345612 [GRCh38]
Chr11:126215507 [GRCh37]
Chr11:11q24.2		 benign|likely benign
NM_014026.6(DCPS):c.868T>G (p.Ser290Ala) single nucleotide variant DCPS-related condition [RCV003943129]|not provided [RCV000964212] Chr11:126345467 [GRCh38]
Chr11:126215362 [GRCh37]
Chr11:11q24.2		 likely benign
NM_014026.6(DCPS):c.637-6A>G single nucleotide variant not provided [RCV001532674] Chr11:126343301 [GRCh38]
Chr11:126213196 [GRCh37]
Chr11:11q24.2		 likely benign
NM_014026.6(DCPS):c.691C>T (p.Arg231Cys) single nucleotide variant Inborn genetic diseases [RCV003276072] Chr11:126343361 [GRCh38]
Chr11:126213256 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.906C>T (p.Ile302=) single nucleotide variant not provided [RCV000908998] Chr11:126345505 [GRCh38]
Chr11:126215400 [GRCh37]
Chr11:11q24.2		 benign|likely benign
NM_014026.6(DCPS):c.972C>T (p.Asp324=) single nucleotide variant not provided [RCV000978402] Chr11:126345571 [GRCh38]
Chr11:126215466 [GRCh37]
Chr11:11q24.2		 likely benign
NM_014026.6(DCPS):c.954C>T (p.Thr318=) single nucleotide variant not provided [RCV000909278] Chr11:126345553 [GRCh38]
Chr11:126215448 [GRCh37]
Chr11:11q24.2		 likely benign
NM_014026.6(DCPS):c.855C>T (p.Phe285=) single nucleotide variant not provided [RCV000909315] Chr11:126345454 [GRCh38]
Chr11:126215349 [GRCh37]
Chr11:11q24.2		 likely benign
NM_014026.6(DCPS):c.717G>A (p.Pro239=) single nucleotide variant DCPS-related condition [RCV003923110]|not provided [RCV000908201] Chr11:126343387 [GRCh38]
Chr11:126213282 [GRCh37]
Chr11:11q24.2		 benign|likely benign
NM_014026.6(DCPS):c.946_949dup (p.Leu317fs) duplication Al-Raqad syndrome [RCV001335611] Chr11:126345541..126345542 [GRCh38]
Chr11:126215436..126215437 [GRCh37]
Chr11:11q24.2		 pathogenic
NM_014026.6(DCPS):c.704C>T (p.Pro235Leu) single nucleotide variant Al-Raqad syndrome [RCV001335609]|Inborn genetic diseases [RCV002547343] Chr11:126343374 [GRCh38]
Chr11:126213269 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.791G>T (p.Arg264Leu) single nucleotide variant Al-Raqad syndrome [RCV001335610] Chr11:126345390 [GRCh38]
Chr11:126215285 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.981dup (p.Leu328fs) duplication Al-Raqad syndrome [RCV001335612] Chr11:126345579..126345580 [GRCh38]
Chr11:126215474..126215475 [GRCh37]
Chr11:11q24.2		 pathogenic
NM_014026.6(DCPS):c.880C>T (p.Arg294Trp) single nucleotide variant not specified [RCV001820308] Chr11:126345479 [GRCh38]
Chr11:126215374 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.865G>A (p.Gly289Ser) single nucleotide variant not specified [RCV002222895] Chr11:126345464 [GRCh38]
Chr11:126215359 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.670C>T (p.Arg224Cys) single nucleotide variant not provided [RCV002511717] Chr11:126343340 [GRCh38]
Chr11:126213235 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.856G>T (p.Glu286Ter) single nucleotide variant Al-Raqad syndrome [RCV003155876] Chr11:126345455 [GRCh38]
Chr11:126215350 [GRCh37]
Chr11:11q24.2		 likely pathogenic
NM_014026.6(DCPS):c.724A>G (p.Arg242Gly) single nucleotide variant not specified [RCV003320507] Chr11:126343394 [GRCh38]
Chr11:126213289 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.861C>T (p.Ala287=) single nucleotide variant not provided [RCV003424919] Chr11:126345460 [GRCh38]
Chr11:126215355 [GRCh37]
Chr11:11q24.2		 likely benign
NM_014026.6(DCPS):c.979del (p.Leu327fs) deletion not provided [RCV003443773] Chr11:126345574 [GRCh38]
Chr11:126215469 [GRCh37]
Chr11:11q24.2		 uncertain significance
NM_014026.6(DCPS):c.897T>C (p.Ala299=) single nucleotide variant not provided [RCV003884317] Chr11:126345496 [GRCh38]
Chr11:126215391 [GRCh37]
Chr11:11q24.2		 likely benign
Markers in Region
SHGC-34118  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3711126,211,598 - 126,211,748UniSTSGRCh37
Build 3611125,716,808 - 125,716,958RGDNCBI36
Celera11123,376,757 - 123,376,907RGD
Cytogenetic Map11q24.2UniSTS
HuRef11122,156,445 - 122,156,595UniSTS
GeneMap99-GB4 RH Map11420.4UniSTS
Whitehead-RH Map11579.8UniSTS
NCBI RH Map111057.0UniSTS
GeneMap99-G3 RH Map115684.0UniSTS
RH104029  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3711126,219,708 - 126,219,855UniSTSGRCh37
Build 3611125,724,918 - 125,725,065RGDNCBI36
Celera11123,384,865 - 123,385,012RGD
Cytogenetic Map11q24.2UniSTS
HuRef11122,164,554 - 122,164,701UniSTS
GeneMap99-GB4 RH Map11417.75UniSTS
G20363  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3711126,215,401 - 126,215,638UniSTSGRCh37
Build 3611125,720,611 - 125,720,848RGDNCBI36
Celera11123,380,558 - 123,380,795RGD
Cytogenetic Map11q24.2UniSTS
HuRef11122,160,246 - 122,160,483UniSTS
A005N41  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3711126,215,401 - 126,215,638UniSTSGRCh37
Build 3611125,720,611 - 125,720,848RGDNCBI36
Celera11123,380,558 - 123,380,795RGD
Cytogenetic Map11q24.2UniSTS
HuRef11122,160,246 - 122,160,483UniSTS
GeneMap99-GB4 RH Map11417.75UniSTS
A008S31  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3711126,212,012 - 126,212,167UniSTSGRCh37
Build 3611125,717,222 - 125,717,377RGDNCBI36
Celera11123,377,171 - 123,377,326RGD
Cytogenetic Map11q24.2UniSTS
HuRef11122,156,859 - 122,157,014UniSTS
GeneMap99-GB4 RH Map11420.3UniSTS
NCBI RH Map111045.3UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High
Medium 6 341 9 355 1 6 4 5 2 29 27
Low 1974 2378 1371 337 1341 203 2578 1227 3407 163 1217 1403 146 1124 1468 4
Below cutoff 362 263 104 96 73 71 1720 943 252 17 13 33 24 80 1306

Sequence


Reference Sequences
RefSeq Acc Id: ENST00000626810
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl11126,350,172 - 126,355,587 (-)Ensembl
RefSeq Acc Id: ENST00000629441
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl11126,340,882 - 126,355,587 (-)Ensembl
RefSeq Acc Id: ENST00000702666
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl11126,341,596 - 126,355,560 (-)Ensembl
RefSeq Acc Id: NR_033839
RefSeq Status: VALIDATED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh3811126,341,716 - 126,355,587 (-)NCBI
GRCh3711126,211,611 - 126,225,482 (-)NCBI
HuRef11122,156,458 - 122,170,332 (-)NCBI
CHM1_111126,097,877 - 126,111,748 (-)NCBI
T2T-CHM13v2.011126,373,121 - 126,386,992 (-)NCBI
Sequence:
Promoters
RGD ID:15096545
Promoter ID:EPDNEWNC_H1385
Type:initiation region
Name:GSEC_1
Description:G-quadruplex forming sequence containing lncRNA[Source:HGNC Symbol;Acc:HGNC:48645]
SO ACC ID:SO:0000170
Source:EPDNEWNC (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh3811126,355,556 - 126,355,616EPDNEWNC

Additional Information

Database Acc Id Source(s)
COSMIC GSEC COSMIC
Ensembl Genes ENSG00000280832 Ensembl
GTEx ENSG00000280832 GTEx
HGNC ID HGNC:48645 ENTREZGENE
Human Proteome Map GSEC Human Proteome Map
NCBI Gene ST3GAL4-AS1 ENTREZGENE
RNAcentral URS000075BEA1 RNACentral


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2017-02-21 GSEC  G-quadruplex forming sequence containing lncRNA  ST3GAL4-AS1  ST3GAL4 antisense RNA 1 (head to head)  Symbol and/or name change 5135510 APPROVED